Showing results (251-260 of 260) with videos related to
Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
Plos Genetics|October 21, 2014
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysisAlexander Pemov, Heejong Sung, Paula L Hyland, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 16, 2025
Development and Evaluation of an Automated Multimodal Mobile Detection of Oral Cancer Imaging System to Aid in Risk-Based Management of Oral Mucosal LesionsRuchika Mitbander, David Brenes, Jackson B Coole, et al.Plant Physiology|April 12, 2000
Activation tagging in ArabidopsisD Weigel, J H Ahn, M A Blázquez, et al.Nature Methods|June 9, 2014
Targeting cells with single vectors using multiple-feature Boolean logicLief E Fenno, Joanna Mattis, Charu Ramakrishnan, et al.Biorxiv : the Preprint Server for Biology|November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2019
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic PainShiwei Steve Liu, Sarah Pickens, Nicole E Burma, et al.Plos Pathogens|September 18, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral familiesMatthew J Vukovich, Andrea R Shiakolas, Jared Lindenberger, et al.Lancet (London, England)|July 29, 2026
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trialCraig M McDonald, Chet Villa, Jonathan H Soslow, et al.Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.Pageof 26